Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  JN. Journal of Nephrology (Milano. 1992)

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s40620-016-0340-3PMID 27485007PMCID PMC5446246
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.

  2016cited by this paper
• Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis

  2016cited by this paper
• Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.

  2014cited by this paper
• Validity of Claims-Based Stroke Algorithms in Contemporary Medicare Data: Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study Linked With Medicare Claims

  2014cited by this paper
• 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

  2014cited by this paper
• Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.

  2014cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations.

  2013cited by this paper
• Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis

  2013cited by this paper
• Use and safety of heparin-free maintenance hemodialysis in the USA.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2013cited by this paper
• Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158 998 patients

  2012cited by this paper
• Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD.

  2012cited by this paper
• Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients.

  2011cited by this paper
• Cardiovascular risk in the peritoneal dialysis patient

  2010cited by this paper
• Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin IIReceptor Blockers for Ischemic Heart Disease

  2009cited by this paper
• Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples

  2009cited by this paper
• Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial.

  2008cited by this paper
• Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.

  2008cited by this paper
• Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis--a randomized study.

  2006cited by this paper
• Clinical practice guidelines for peritoneal dialysis adequacy.

  2006cited by this paper
• K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease

  2004cited by this paper
• Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records.

  2004cited by this paper
• K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.

  2004cited by this paper
• Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction.

  2003cited by this paper
• Bradykinin Contributes to the Vasodilator Effects of Chronic Angiotensin-Converting Enzyme Inhibition in Patients With Heart Failure

  2001cited by this paper
• Marginal Structural Models and Causal Inference in Epidemiology

  2000cited by this paper
• Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer.

  2000cited by this paper
• Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients.

  1998cited by this paper
• Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure.

  1998cited by this paper
• Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor.

  1994cited by this paper

• Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study

  2024cites this paper
• Comparison between the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and their combination on mortality in maintenance dialysis patients: a systematic review and meta-analysis

  2024cites this paper
• Uncertainties in BP management in dialysis patients

  2020cites this paper
• Angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use prior to medical intensive care unit admission and in-hospital mortality: propensity score-matched cohort study

  2019cites this paper
• Novel phthalamide derivatives as antihypertensive agents: rapid and clean synthesis, in silico and in vivo evaluation

  2019cites this paper
• The comparison of risk of stroke in patients with peritoneal dialysis and hemodialysis: A systematic review and meta‐analysis

  2018cites this paper
• 2. 腹膜透析 (PD)

  2016cites this paper